Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8133 ↗At a glance
Journal article in Phytotherapy Research, 2024. Written by Alessio Ardizzone and 11 co-authors. Institution: Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy. Major MEDLINE topics: Pea Proteins, Gastroesophageal Reflux, Glucans, Xylans. Cited 3 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Gastroesophageal reflux disease (GERD) is the most common foregut disease, affecting about 20% of the adult population. Esophageal epithelial barrier plays a fundamental role in the pathophysiology of GERD; however, pharmacological therapies mainly aim to reduce the acidity of the gastroesophageal environment rather than to protect esophageal tissue integrity. This study aims to evaluate the efficacy of an oral solution containing xyloglucan and pea proteins (XP) in reestablishing gastroesophageal tissue integrity and biochemical markers. To induce GERD, C57BL/6 mice were alternatively overfed and fasted for 56 days and then treated with XP, sodium alginate, omeprazole, or omeprazole+XP twice daily for 7 days. Gastric pain and inflammatory markers were evaluated after 3 and 7 days of treatment. After sacrifice, the esophagi and stomachs were surgically removed for macroscopic and histological examination. Gastric pain was significantly reduced at days 3 and 7 by XP, omeprazole, and omeprazole+XP, while alginates were ineffective at day 3. XP was able to diminish gastric macroscopic damage and demonstrated the same efficacy as omeprazole in reducing esophageal damage. XP significantly reduced histological damage, with an efficacy comparable to that of omeprazole, but superior to alginates. Inflammatory markers were significantly reduced by XP, with superior efficacy compared with alginates at day 7. Interestingly, XP was also able to significantly increase gastric pH. This study demonstrated that XP restored gastric homeostasis, improved esophageal integrity, and decreased inflammation and pain with a similar efficacy to omeprazole and greater than alginates.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.
ORCID profiles: Alessio Ardizzone, Emanuela Esposito
Cite
APA
Ardizzone, A., Mannino, D., Casili, G., Campolo, M., Paterniti, I., Lanza, M., Filippone, A., Repici, A., Bova, V., Capra, A. P., Cuzzocrea, S., & Esposito, E. (2024). Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease. Phytotherapy Research. https://doi.org/10.1002/ptr.8133
Vancouver
Ardizzone A, Mannino D, Casili G, Campolo M, Paterniti I, Lanza M, et al. Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease. Phytotherapy Research. 2024. doi:10.1002/ptr.8133
BibTeX
@article{Ardizzone2024,
author = {Ardizzone, Alessio and Mannino, Deborah and Casili, Giovanna and Campolo, Michela and Paterniti, Irene and Lanza, Marika and Filippone, Alessia and Repici, Alberto and Bova, Valentina and Capra, Anna Paola and Cuzzocrea, Salvatore and Esposito, Emanuela},
title = {Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8133}
}
EUVIMED